Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Bont

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
Expert Review of Anti-Infective Therapy|March 20, 2025
Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in childrenXavier Carbonell-Estrany, Eric A F Simões, Louis Bont, et al.
Emerging Infectious Diseases|May 20, 2021
Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species LevelVahid Salimi, Mariana Viegas, Alfonsina Trento, et al.
The Lancet. Infectious Diseases|August 11, 2022
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscapeNatalie I Mazur, Jonne Terstappen, Ranju Baral, et al.
Lancet (London, England)|July 11, 2017
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling studyTing Shi, David A McAllister, Katherine L O'Brien, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
Expert Review of Anti-Infective Therapy|March 20, 2025
Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in childrenXavier Carbonell-Estrany, Eric A F Simões, Louis Bont, et al.
Emerging Infectious Diseases|May 20, 2021
Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species LevelVahid Salimi, Mariana Viegas, Alfonsina Trento, et al.
The Lancet. Infectious Diseases|August 11, 2022
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscapeNatalie I Mazur, Jonne Terstappen, Ranju Baral, et al.
Lancet (London, England)|July 11, 2017
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling studyTing Shi, David A McAllister, Katherine L O'Brien, et al.
Pageof 18